3 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2016
-
07/2009 |
3 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
11/2008
-
12/2007 |
3 | HexokinaseIBA
11/2008
-
01/2008 |
2 | AdipokinesIBA
01/2022
-
12/2015 |
2 | Bevacizumab (Avastin)FDA Link
04/2014
-
01/2011 |
2 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014
-
01/2011 |
2 | Glucose (Dextrose)FDA LinkGeneric
11/2008
-
02/2008 |
2 | Deoxyglucose (2 Deoxy D glucose)IBA
02/2008
-
02/2007 |
1 | ChemokinesIBA
05/2021 |
1 | CytokinesIBA
05/2021 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
02/2016 |
1 | Peptides (Polypeptides)IBA
02/2016 |
1 | Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2016 |
1 | Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2016 |
1 | Chelating AgentsIBA
02/2016 |
1 | AdiponectinIBA
12/2015 |
1 | CCR5 Receptor AntagonistsIBA
12/2014 |
1 | src-Family KinasesIBA
12/2014 |
1 | Biomarkers (Surrogate Marker)IBA
03/2014 |
1 | Messenger RNA (mRNA)IBA
11/2013 |
1 | human ERBB2 proteinIBA
11/2013 |
1 | PhosphatidylserinesIBA
04/2012 |
1 | 64Cu-DOTA-cetuximabIBA
07/2011 |
1 | Cetuximab (Erbitux)FDA Link
07/2011 |
1 | Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2011 |
1 | Dialysis SolutionsIBA
09/2010 |
1 | IronIBA
09/2010 |
1 | Monoclonal AntibodiesIBA
04/2010 |
1 | Trastuzumab (Herceptin)FDA Link
04/2010 |
1 | Pharmaceutical PreparationsIBA
02/2010 |
1 | SolutionsIBA
08/2009 |
1 | Octreotide (Sandostatin)FDA LinkGeneric
08/2009 |
1 | Somatostatin Receptors (Somatostatin Receptor)IBA
08/2009 |
1 | AcidsIBA
08/2009 |
1 | Indium-111IBA
07/2009 |
1 | Yttrium-90IBA
07/2009 |
1 | Alexa Fluor 750IBA
07/2009 |
1 | Membrane Proteins (Integral Membrane Proteins)IBA
07/2009 |
1 | Contrast MediaIBA
04/2009 |
1 | Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2008 |
1 | alpha-Methyltyrosine (Metirosine)FDA Link
02/2007 |